NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office. The products launched under its flagship medical Ceed brand and are comprised of four formulations that will be a

READ MORE: http://www.businesswire.com/news/home/20211214005485/en/%C2%A0Columbia-Care-Launches-the-UK%E2%80%99s-Broadest-Portfolio-of-Doseable-Medical-Cannabis-Extract-Vaporizer-Pens-First-Company-to-Manufacture-Extract-Vaporization-Products-in-the-UK/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhB8bDel5XZmwWFQYQPHxx__rCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3kCXJZE-1b1nXn968wYfofVLkaZDLiczsahzEklD3R10Q==